Ambit Biosciences Secures $64,800,000 New Financing

  • Feed Type
  • Date
    5/16/2013
  • Company Name
    Ambit Biosciences
  • Mailing Address
    4215 Sorrento Valley Blvd. San Diego, CA 92121
  • Company Description
    Ambit Biosciences (NASDAQ: AMBI) is a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.
  • Website
    http://www.ambitbio.com
  • Transaction Type
    IPO
  • Transaction Amount
    $64,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.